Clinical Trial Update: Intravesical Gentamicin to Prevent Recurrent UTI [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating intravesical gentamicin to prevent recurrent urinary tract infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Tract Infection

Drugs mentioned

• Gentamicin (gentamicin)

Snippet

Sponsor: Women and Infants Hospital of Rhode Island | Conditions: Recurrent Uti | Phase 4 | Status: COMPLETED